We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PFG:NASDAQPrincipal Financial Group Inc Analysis

Data as of 2026-03-10 - not real-time

$89.73

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Principal Financial Group trades just above its near‑term support level, with the 20‑day SMA still above the 50‑day and 200‑day averages, indicating a lingering bullish bias despite a recent dip. The RSI hovering just below 40 hints at modest oversold pressure, yet the MACD histogram remains in negative territory, flagging bearish momentum and a decreasing volume trend. Recent earnings missed consensus estimates, and a JPMorgan downgrade adds short‑term uncertainty, while the company continues to deliver a solid dividend yield of roughly 3.4% on a payout ratio under 60%, supporting income‑focused investors.
Fundamentally, a forward PE near 9 suggests cheap valuation relative to earnings growth expectations, but the discounted cash‑flow model places fair value well below the current price, implying the stock may be overvalued in the near term. The balance of a strong cash position, moderate leverage, and a dividend that appears sustainable points to a more favorable outlook over the medium to long horizon, provided earnings momentum can be re‑established.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Q4 earnings missed consensus estimates
  • Bearish MACD momentum and decreasing volume
  • Price near technical support with limited upside

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Attractive dividend yield and sustainable payout
  • Forward PE compression indicating earnings growth
  • Target price suggests modest upside above current levels

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong cash position and manageable debt
  • Revenue contraction raises growth concerns
  • Dividend sustainability supports total return

Key Metrics & Analysis

Financial Health

Revenue Growth-3.70%
Profit Margin7.58%
P/E Ratio17.1
ROE10.52%
ROA0.28%
Debt/Equity34.91
P/B Ratio1.6
Op. Cash Flow$4.5B
Free Cash Flow$1.0B
Industry P/E17.3

Technical Analysis

TrendBullish
RSI40.0
Support$87.96
Resistance$97.59
MA 20$93.20
MA 50$92.44
MA 200$83.96
MACDBearish
VolumeDecreasing
Fear & Greed Index76.91

Valuation

Fair Value$71.89
Target Price$94.73
Upside/Downside5.57%
GradeOvervalued
TypeBlend
Dividend Yield3.45%

Risk Assessment

Beta1.14
Volatility27.45%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.